Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Long-Term Investments (2021 - 2023)

Agilon Health's Long-Term Investments history spans 3 years, with the latest figure at $5.1 million for Q1 2023.

  • For Q1 2023, Long-Term Investments fell 28.86% year-over-year to $5.1 million; the TTM value through Mar 2023 reached $5.1 million, down 28.86%, while the annual FY2022 figure was $4.7 million, 27.01% down from the prior year.
  • Long-Term Investments reached $5.1 million in Q1 2023 per AGL's latest filing, up from $4.7 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $7.2 million in Q1 2022 to a low of $3.6 million in Q2 2022.
  • Average Long-Term Investments over 3 years is $5.6 million, with a median of $5.8 million recorded in 2021.
  • Peak YoY movement for Long-Term Investments: dropped 27.01% in 2022, then decreased 28.86% in 2023.
  • A 3-year view of Long-Term Investments shows it stood at $6.4 million in 2021, then fell by 27.01% to $4.7 million in 2022, then rose by 10.5% to $5.1 million in 2023.
  • Per Business Quant, the three most recent readings for AGL's Long-Term Investments are $5.1 million (Q1 2023), $4.7 million (Q4 2022), and $6.4 million (Q3 2022).